AGP Picks
View all

Senate Resolution 375 Printer's Number 1961

PENNSYLVANIA, September 25 - PRINTER'S NO. 1961

THE GENERAL ASSEMBLY OF PENNSYLVANIA

SENATE RESOLUTION

No.

375

Session of

2026

INTRODUCED BY CULVER, MARTIN, HAYWOOD, STREET, CAPPELLETTI,

VOGEL, PHILLIPS-HILL, HUGHES, KANE, COSTA AND STEFANO,

SEPTEMBER 25, 2026

REFERRED TO RULES AND EXECUTIVE NOMINATIONS, SEPTEMBER 25, 2026

A RESOLUTION

Designating the month of September 2026 as "Histiocytosis

Awareness Month" in Pennsylvania.

WHEREAS, The observance of "Histiocytosis Awareness Month"

serves to increase public awareness of this group of rare

disorders that occur when there is an overproduction of white

blood cells known as histiocytes, which can lead to organ damage

and tumor formation; and

WHEREAS, Histiocytic disorders are classified into five main

groups, which have helped create a common language for diagnosis

and treatment of these rare disorders; and

WHEREAS, Research over the last 15 to 20 years has advanced

the understanding of the disorders; and

WHEREAS, Discoveries of cancer-causing mutations aided in

classifying a few of the disorders as rare cancers, known as

histiocytic neoplasms; and

WHEREAS, Histiocytic disorders are very rare and not widely

recognized by the general public or even within the medical

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Harrisburg Wellness Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.